Stay current on the healthcare enforcement issues impacting your business’ compliance strategies. In this installment of the Healthcare Enforcement Roundup, we address:
- Key areas of enforcement scrutiny in 2021, including growing numbers of relator complaints under the False Claims Act, COVID-19-related enforcement, and ongoing attention to private equity;
- Timely updates on Section 1135 waivers, telemedicine-related issues, and further interpretation regarding the enforceability of sub-regulatory guidance;
- The Office of Inspector General’s Special Fraud Alert, which provides important guidelines for pharmaceutical and medical device speaker programs; and
- Pertinent developments in cases and other enforcement matters covered in prior issues.
